Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Are Value Frameworks Missing the Mark When Considering Long-term Benefits From Immuno-oncology Drugs?

Schnipper LE, Schilsky RL. Are Value Frameworks Missing the Mark When Considering Long-term Benefits From Immuno-oncology Drugs? JAMA Oncol. 2018 03 01; 4(3):333-334.

View in: PubMed

collapse authors with profiles